⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LRMR News
Larimar Therapeutics, Inc. Common Stock
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering
globenewswire.com
LRMR
Biotech and Big Tech Drive the Morning Narrative
globenewswire.com
VIR
LRMR
META
AMD
Form 8-K
sec.gov
LRMR
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026
globenewswire.com
LRMR
Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
LRMR
Larimar Therapeutics Reports Third Quarter 2025 Financial Results
globenewswire.com
LRMR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
accessnewswire.com
LRMR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
accessnewswire.com
LRMR
Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – LRMR
businesswire.com
LRMR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
prnewswire.com
LRMR